The Board of Directors of BB Biotech AG will propose a regular dividend of CHF 3.05 per share for the year 2018, at the general assembly on March 21, 2019. This is computed as a 5% dividend yield applied to the average share price of December 2018 consistent with the dividend policy introduced in 2013.